Progress in diagnosis and treatment of difficult-to-treat asthma in children

Area of Science:

• Pediatric Pulmonology
• Allergy and Immunology
• Clinical Therapeutics

Background:

• Inhaled corticosteroids (ICS) are primary treatments for pediatric asthma.
• A subset of children, termed difficult-to-treat asthma (DA), show poor symptom control despite maximal ICS therapy.
• DA presents significant challenges due to its heterogeneity, impacting treatment efficacy and patient health.

Purpose of the Study:

• To review the current understanding of difficult-to-treat asthma (DA) in children.
• To provide a comprehensive overview of DA definition, diagnostic evaluation, and therapeutic approaches.
• To offer guidance for clinicians in managing pediatric DA for improved outcomes.

Main Methods:

• Literature review of studies on pediatric difficult-to-treat asthma.
• Analysis of existing definitions and diagnostic criteria for DA.
• Synthesis of current evidence on treatment strategies for DA.

Main Results:

• Difficult-to-treat asthma (DA) is characterized by persistent symptoms despite optimal inhaled corticosteroid (ICS) treatment.
• Accurate identification of DA is complex due to its heterogeneous nature.
• Current treatment approaches for DA require tailored strategies beyond standard ICS.

Conclusions:

• Standardized ICS therapy is insufficient for all pediatric asthma patients.
• A clear definition and systematic evaluation are crucial for identifying children with difficult-to-treat asthma (DA).
• Optimizing clinical decision-making for DA management requires a comprehensive approach to treatment.